Daniel S. Levine
LightNews LightNews
banner
dslevine.bsky.social
Daniel S. Levine
@dslevine.bsky.social
49 followers 38 following 150 posts
Principal, Levine Media Group, host of The Bio Report and RARECast podcasts, award-winning journalist focused on the life sciences.
Posts Replies Media Videos
dslevine.bsky.social
Jeffrey Brown CSO of TriNetX, discusses how real-world data can address common challenges in rare disease research, the hurdles that need to be addressed, and how advances in AI could revolutionize rare disease research. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/tr...
Transforming Real-Word Patient Data into Breakthroughs
Jeff Brown, chief scientific officer of TriNetX, discusses how real-world data can address common challenges in rare disease research, the hurdles that need to be addressed, and how advances in AI cou...
globalgenes.org
November 7, 2025 at 5:15 PM
dslevine.bsky.social
Brian Weitzner, co-founder of OpenFold, discusses the collaborative effort to develop software and AI tools to predict the 3D structure of proteins, how its open licensing model ensures broad accessibility, and how it stacks up against AlphaFold.

thebioreport.podbean.com/e/an-ai-coll...
November 5, 2025 at 3:24 PM
dslevine.bsky.social
Here's what you may have missed in October from The Bio Report, RARECast, and Life Sciences D'n'A podcasts.
www.linkedin.com/pulse/why-us...
Why the U.S. Must Fall in Love with Biotech, Rare Disease Advocates Push FDA for Timely Reviews, and Driving Insights from Real-World Data and AI
Here's what you may have missed in October from The Bio Report, RARECast, and Life Sciences D'n'A podcasts. The Bio Report Hitting the Reset Button on Cellular Aging Transcription factors control the ...
www.linkedin.com
November 3, 2025 at 8:51 PM
dslevine.bsky.social
Prarthana Khanna, VP of corporate business development and strategy for Vico Therapeutics, discusses Huntington's disease, the company’s experimental ASO, and why it has the potential to address multiple neurological diseases. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/ta...
Taking Aim at Huntington’s Disease and Other Repeat Expansion Disorders
Prarthana Khanna, vice president of corporate business development and strategy for Vico, discusses Huntington's disease, the company’s experimental ASO to target the disease, and why it has the poten...
globalgenes.org
October 31, 2025 at 2:39 PM
dslevine.bsky.social
John Hoekman, co-founder and CEO of Junevity, discusses the role of transcription factors in healthy biology and aging-related disease, the company’s AI-driven platform, and its lead programs targeting type 2 diabetes and obesity.

thebioreport.podbean.com/e/hitting-th...
October 29, 2025 at 3:10 PM
dslevine.bsky.social
Philippa Ward discusses her journey as the mother of a child diagnosed with tuberous sclerosis complex, the challenges posed by the condition’s complexities, and how she found both a community and her own voice as an advocate. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/le...
Learning to Be a Caregiver and Advocate
Philippa Ward discusses her journey as the mother of a child diagnosed with tuberous sclerosis complex, the challenges posed by the condition’s complexities, and how she found both a community of supp...
globalgenes.org
October 24, 2025 at 3:04 PM
dslevine.bsky.social
Aaron Cohen, Head of Research Oncology, Clinical Data at Flatiron Health, joins Amar Drawid, on Life Sciences DNA to explore how large language models are transforming oncology research.

www.youtube.com/watch?v=W-Gq...
Driving Insights from Real World Oncology Data with AI
YouTube video by Life Sciences DNA Podcast
www.youtube.com
October 23, 2025 at 7:59 PM
dslevine.bsky.social
Stacy Lindborg, CEO of Imunon, discusses the company’s DNA-mediated immunotherapy, how it avoids the systemic toxicities that undermined earlier IL-12 approaches, and how it could change the treatment landscape for the disease.

thebioreport.podbean.com/e/changing-t...
October 22, 2025 at 2:23 PM
dslevine.bsky.social
The Rwanda FDA approved @BioUsawa 's BioUcenta, a biosimilar of Lucentis. It is the first biosimilar ranibizumab approved in Africa and represents the first major regulatory milestone for Bio Usawa.

www.globenewswire.com/news-release...
Bio Usawa Announces Approval of BioUcenta™ by the Rwandan FDA
BioUcenta™ is the first biosimilar of Lucentis (ranibizumab) approved in Africa...
www.globenewswire.com
October 20, 2025 at 8:43 PM
dslevine.bsky.social
Laura Russo, U.S. patient engagement lead for Pfizer, discusses how the company’s patient-facing teams work to bridge health systems and patient communities to improve access and care. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/im...
Improving Rare Disease Care through Partnerships
Laura Russo, U.S. patient engagement lead for Pfizer, discusses how the company’s patient-facing teams work to bridge health systems and patient communities, how they help people with rare diseases na...
globalgenes.org
October 17, 2025 at 2:44 PM
dslevine.bsky.social
Drew Endy, senior fellow of the Hoover Institution, discusses China’s all-of-nation strategy, how the United States has misallocated research dollars, and why a cultural embrace of biotechnology will be critical for the success of either country.

thebioreport.podbean.com/e/why-the-un...
Why the United States Must Fall in Love with Biotechnology, or Take a Back Seat to China | The Bio Report
China’s emergence as a biotech superpower may have appeared to happen suddenly, but it reflected a long-term vision and policies over many years that enabled its success. As biotechnology transforms n...
thebioreport.podbean.com
October 15, 2025 at 2:59 PM
dslevine.bsky.social
Kristin McKay, CEO of Project Alive, discusses the need for new therapies for Hunter syndrome, the importance of early detection, and the patient community’s concerns with regulatory delays in approving needed treatments. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/a-...
A Call on the FDA for Timely Reviews of Life-Saving Therapies for Rare Diseases
Kristin McKay, CEO of the Hunter syndrome patient advocacy organization Project Alive, about the need for new therapies, the importance of early detection, and the patient community’s concerns with re...
globalgenes.org
October 10, 2025 at 2:33 PM
dslevine.bsky.social
Arc Institute’s Hani Goodarzi, Ultima Genomics' Gilad Almogy, and 10X Genomics' Serge Saxonov discuss the ARC Virtual Cell Atlas, which uses single-cell genomics, AI, and open science to understand the complexities of cellular behavior.

thebioreport.podbean.com/e/transformi...
Transforming Drug Discovery and Disease Research—One Cell at a Time | The Bio Report
The ARC Virtual Cell Atlas uses high-throughput single-cell genomics, artificial intelligence, and open science to understand the complexities of cellular behavior. Developed through a partnership bet...
thebioreport.podbean.com
October 8, 2025 at 2:28 PM
dslevine.bsky.social
Amélie Lothe, global medical community head for rare epilepsies at UCB, discusses the importance of looking beyond seizures to view developmental and epileptic encephalopathies as complex neurodevelopmental conditions. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/th...
The Need to Look Beyond Seizures When Treating DEEs
Amelie Lothe, global medical community head for rare epilepsies at UCB, about the importance of viewing developmental and epileptic encephalopathies as complex neurodevelopmental conditions, the need ...
globalgenes.org
October 3, 2025 at 5:19 PM
dslevine.bsky.social
Marc Salzberg, CEO of Airway Therapeutics, discusses the company’s experimental therapy zelpultide alfa to treat preterm infants with a rare lung disease, why it’s a pipeline-in-a-product, and its development path forward.

thebioreport.podbean.com/e/scratching...
October 1, 2025 at 2:07 PM
dslevine.bsky.social
Here's what you may have missed in September from The Bio Report, RARECast, and Life Sciences D'n'A podcasts.

www.linkedin.com/pulse/extend...
Extending the Life of Transplanted Kidneys, Changing the Playbook on Childhood Cancers, and Navigating AI in Clinical Development
Here's what you may have missed in September from The Bio Report, RARECast, and Life Sciences D'n'A podcasts. The Bio Report A Dual Action Approach to Treating MASH MASH, a chronic and progressive for...
www.linkedin.com
September 30, 2025 at 3:04 PM
dslevine.bsky.social
Todd Harris, CEO of Tyra Biosciences, discusses the company’s experimental oral medicine for achondroplasia, studies conducted to date, and why he believes it will offer competitive advantages over existing therapies. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/ta...
Taking On Big Competitors with an Oral Therapy to Treat Achondroplasia
Todd Harris, CEO of Tyra Biosciences, discusses the company’s experimental once-daily, oral medicine for achondroplasia; what’s known about it from studies conducted to date, and why he believes it wi...
globalgenes.org
September 26, 2025 at 4:16 PM
dslevine.bsky.social
What happens when AI touches every role, every day, in clinical development? Stephen Pyke of @parexel.bsky.social, in conversation with Nagaraja Srivatsan, highlights why preparing teams early is essential to unlock their full potential.

trials?https://www.youtube.com/watch?v=gNTNJhLfzT0&t=1s
September 25, 2025 at 3:05 PM
dslevine.bsky.social
Rohan Palekar, CEO of 89bio, discusses what’s driving the prevalence of MASH, the limits of existing medicines, and how the company’s experimental therapy targets both liver fibrosis and the underlying metabolic dysfunctions of the disease.

thebioreport.podbean.com/e/a-dual-act...
September 24, 2025 at 2:16 PM
dslevine.bsky.social
Paul Peter Tak, president and CEO of Candel Therapeutics, discusses the company's viral immunotherapy for brain cancer, how it works, and what clinical studies have shown to date. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/65...
Going Viral to Fight Brain Cancer
Paul Peter Tak, president and CEO of Candel Therapeutics, discsses its viral immunotherapy, how it works, and what clinical studies have shown to date.
globalgenes.org
September 19, 2025 at 6:37 PM
dslevine.bsky.social
Steve Perrin, CSO of Eledon Pharmaceuticals, discusses the need for innovative approaches to immunosuppression in organ transplantation, how its experimental therapy works, and why it may have benefits in autoimmune and neurodegenerative diseases as well.
thebioreport.podbean.com/e/extending-...
September 17, 2025 at 4:15 PM
dslevine.bsky.social
David Jenkinson of @lifearc.bsky.social discusses the children’s cancer therapeutics consortium C-Further, the challenges of developing treatments for childhood cancers, and why new models for advancing these therapies are needed. @globalgenes.bsky.social #RARECast

open.spotify.com/episode/13td...
September 12, 2025 at 3:06 PM
dslevine.bsky.social
Mohan Uttarwar, CEO of @1Cell.Ai discusses how AI-powered cell biopsy could make cancer monitoring more accessible, minimally invasive, and transformative for millions of patients worldwide

www.agilisium.com/podcast/tran...
Transforming Cancer Diagnostics and Care with AI
Explore how Mohan Uttarwar and Amar Drawid discuss AI-powered cell biopsy, early cancer detection, and the future of precision oncology.
www.agilisium.com
September 11, 2025 at 4:07 PM
dslevine.bsky.social
Greg Mario, CEO of Taxis Pharmaceuticals, discusses the public health threat posed by drug-resistant gonorrhea, the approaches it’s taking to develop new antimicrobial treatments, and the need for new funding models to bring new therapies to market.

thebioreport.podbean.com/e/overcoming...
September 10, 2025 at 2:25 PM
dslevine.bsky.social
Robin Williams of UofM Masonic Children's Hospital describes the medical mystery of a 15-year-old who became critically ill when he was admitted into a PICU and what it took to diagnose him with the ultra-rare disease TAFRO. @globalgenes.bsky.social #RARECast

globalgenes.org/raredaily/so...
Sometimes the Hoofbeats Do Belong to Zebras
Robin Williams, assistant professor of pediatric hematology/oncology at the University of Minnesota Masonic Children's Hospital, describes the case of Avion, a 15-year-old who became critically ill wh...
globalgenes.org
September 5, 2025 at 4:37 PM